Supplemental vitamin D and physical performance in COPD: a pilot randomized trial
Sonja M Bjerk,1 Bradley D Edgington,1 Thomas S Rector,1,2 Ken M Kunisaki1,2
1University of Minnesota, 2Minneapolis VA Health Care System, Minneapolis, MN, USA
Background: Low 25-hydroxyvitamin D (25[OH]D) levels, commonly observed in chronic obstructive pulmonary disease (COPD), are associated with muscle weakness in elderly populations, and vitamin D supplementation appears to improve muscle strength and decrease falls in older individuals. We tested the effect of vitamin D supplementation on physical performance in patients with COPD.
Methods: Patients were randomized to daily cholecalciferol (2000 IU) or placebo for 6 weeks. The primary outcome was the 6-week change in Short Physical Performance Battery (SPPB) score. Secondary outcomes included changes in the St George’s Respiratory Questionnaire (SGRQ) score, and serum 25(OH)D.
Results: Thirty-six participants (mean age 68 years, all Caucasian males, mean forced expiratory volume in one second 33% of predicted) completed the study. Despite an increase in 25(OH)D levels in the intervention arm to a mean of 32.6 ng/mL (versus 22.1 ng/mL in the placebo arm), there was no difference in improvements in either SPPB scores (0.3 point difference; 95% confidence interval -0.8 to 1.5; P = 0.56) or SGRQ scores (2.3 point difference; 95% confidence interval -2.3 to 6.9; P = 0.32).
Conclusion: Among patients with severe COPD, 2000 IU of daily vitamin D for 6 weeks increased 25(OH)D to a level widely considered as normal. However, compared with placebo, short-term vitamin D supplementation had no discernible effect on a simple measure of physical performance.
Keywords: chronic obstructive pulmonary disease, randomized controlled trial, vitamin D, skeletal muscle strength
Other article by this author:
Ken M Kunisaki, Thomas S Rector
Published Date: 7 January 2011
Readers of this article also read:
Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study [Corrigendum]
Bisht B, Darling WG, Shivapour ET, Lutgendorf SK, Snetselaar LG, Chenard CA, Wahls TL
Published Date: 10 September 2015
Does how much a resident teaches impact performance? A comparison of preclinical teaching hours to pathology residents’ in-service examination scores
Talmon GA, Czarnecki DK, Sayles HR
Published Date: 20 April 2015
Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications
Weisman JA, Nicholson JC, Tappa K, Jammalamadaka UB, Wilson CG, Mills DK
Published Date: 9 January 2015
Wainstein AJA, Drummond-Lage AP, Kansaon MJM, Bretas GO, Almeida RF, Gloria ALF, Figueiredo ARP
Published Date: 16 December 2014
Support for the initial attachment, growth and differentiation of MG-63 cells: a comparison between nano-size hydroxyapatite and micro-size hydroxyapatite in composites
Filová E, Suchý T, Sucharda Z, Šupová M, Žaloudková M, Balík K, Lisá V, Šlouf M, Bačáková L
Published Date: 6 August 2014
Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD: are there new key cornerstones?
Esquinas AM, Confalonieri M
Published Date: 30 January 2014
Crema M, Verbano C
Published Date: 13 November 2013
Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C
Published Date: 18 September 2013
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol
Published Date: 14 February 2013
Associations between isokinetic muscle strength, high-level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease
Butcher SJ, Pikaluk BJ, Chura RL, Walkner MJ, Farthing JP, Marciniuk DD
Published Date: 22 August 2012